BioMarin Pharmaceutical, Inc. (BMRN)
NGS · Common · CUSIP 09061G101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BMRN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
09061G101
Market Cap
Large Cap · $17 Billion
IPO
7/23/1999 · $13.00/share
Business: BioMarin Pharmaceutical Inc. is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of commercialized products as well as multiple clinical and pre-clinical product candidates.

Company Contact

CEO
Jean-Jacques Bienaime
CFO
Daniel K. Spiegelman
Headquarters
105 Digital Drive, Novato, CA 94949
Phone
415-506-6700
Fax
415-382-7889
Investor Relations
Traci McCarty · 415-455-7558 · ir@bmrn.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »